Strains
Strain name: iVS-1®
Full name: Bifidobacterium adolescentis
iVS-1® is an ecologically-advanced® probiotic, Bifidobacterium adolescentis iVS-1®. It was discovered by our leading scientific experts, with four published papers on the strain from inception to clinical trial
(Krumbeck et al., 2018).
In humans, iVS-1® is demonstrated to:
-
Clinically shown to support gut barrier integrity, which impacts important aspects of the immune system and the body’s metabolism
-
Reached a 10x higher level in the gut than a leading strain of Bifidobacterium in a randomized, double-blind, placebo-controlled clinical trial
-
Persists longer in the gut
-
Helps maintain and support a healthy immune system
-
Supports digestive health
-
May support healthy metabolic function
-
Clinically demonstrated to increase the total amount of bifidobacteria in the human gut. Bifidobacterium levels have been shown to decrease as we age
-
Supports a tight gut lining
-
Helps balance the microbiome
-
iVS-1® has been clinically paired with the targeted prebiotic GOS, which it competitively consumes
-
Native to the human gut
-
Effective clinical doses as low as 1 Billion CFU per day
Clinical Dosage:
NoviaHealth offers B. adolescentis iVS-1® as a bulk powder or in finished product formulation. B. adolescentis iVS-1® is effective at doses as low as 1 Billion CFU per day. Optionally, the strain may be combined with a partner prebiotic, galactooligosaccharide (GOS), to create a ‘complementary synbiotic’ ingredient.
iVS-1® is suitable for delivery in various dietary supplement product forms, and in select food product types.
